ResearcherShandong Provincial QianFoShan HospitalNo recent work listed

Peng Dong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3233-5708; OpenAlex author ID A5004452981. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper

Papers 2

The Role of Myeloid-Derived Suppressor Cells in the Treatment of Pancreatic Cancer. Co-author DOI 10.1177/15330338221142472 ↗
Identification of N6-Methyladenosine-Associated Long Non-coding RNAs for Immunotherapeutic Response and Prognosis in Patients With Pancreatic Cancer. First author DOI 10.3389/fcell.2021.748442 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xinshuang Yu · 2 shared papers, 2021–2022 · strength 0.27
- Paper The Role of Myeloid-Derived Suppressor Cells in the Treatment of Pancreatic Cancer. DOI 10.1177/15330338221142472 ↗
- Paper Identification of N6-Methyladenosine-Associated Long Non-coding RNAs for Immunotherapeutic Response and Prognosis in Pa… DOI 10.3389/fcell.2021.748442 ↗
Fengjun Liu · 2 shared papers, 2021–2022 · strength 0.27
- Paper The Role of Myeloid-Derived Suppressor Cells in the Treatment of Pancreatic Cancer. DOI 10.1177/15330338221142472 ↗
- Paper Identification of N6-Methyladenosine-Associated Long Non-coding RNAs for Immunotherapeutic Response and Prognosis in Pa… DOI 10.3389/fcell.2021.748442 ↗
Sanyuan Hu · 1 shared paper, 2021 · strength 0.13
- Paper Identification of N6-Methyladenosine-Associated Long Non-coding RNAs for Immunotherapeutic Response and Prognosis in Pa… DOI 10.3389/fcell.2021.748442 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.